Editorial team
ioQuanta Research Desk
-
Evidence date ·How changing a drug carrier could matter for cancer immunotherapy
Review or Meta-AnalysisA 2022 review examines modifiable chitosan carriers for cancer immunotherapy. Its abstract does not establish benefits for patients.
-
Evidence date ·Why directing immune signals may matter more than simply increasing them in lymphoma treatment
Review or Meta-AnalysisA 2022 review explains IL-2’s competing effects, what IL-12–rituximab trials reveal, and how targeted or engineered signals might help lymphoma care.
-
Evidence date ·How tiny gold particles could carry treatment and help immune cells recognize breast cancer
Review or Meta-AnalysisA 2022 mini review explains how tiny gold particles carry immune-active treatments or turn tumor damage into immune signals, without proving patient protection.
-
Evidence date ·How reversible bonds help a self-healing electrolyte maintain electrode contact
Peer-Reviewed PaperTracked over timeResearchers combined two reversible bond types in a polymer electrolyte, then tested high-voltage lithium cells and pouch prototypes with limited safety evidence.
-
Evidence date ·How charged groups could help a simulated battery electrolyte heal and carry lithium
Peer-Reviewed PaperTracked over timeSimulations explore how a charged polymer could repair damage and carry lithium ions, offering a possible route to longer-lasting anode-free batteries.
-
Evidence date ·How a self-healing electrolyte performed with a high-voltage cathode
Peer-Reviewed PaperTracked over timeThe study describes a polymer electrolyte that repairs lithium-interface damage and reports 80.4% capacity retention after 500 cycles.
-
Evidence date ·What inherited short-sleep mutations reveal about Alzheimer pathology in mice
Peer-Reviewed PaperMouse models carrying two inherited short-sleep mutations developed less tau and amyloid pathology, but sleep’s role and human benefit remain unresolved.
-
Evidence date ·What patient questionnaires reveal when treatment assignments are known
Review or Meta-AnalysisA review of 23 immunotherapy trials found no baseline design-related difference in questionnaire completion or scores, while follow-up effects remained unresolved.
-
Evidence date ·How cells that stop dividing may disturb bone renewal
Review or Meta-AnalysisA February 2022 review explains how senescent cells may disrupt bone renewal, what mouse studies and early human work measured, and why dosing matters.
-
Evidence date ·How accumulated damage and recovery capacity shape aging with HIV
Peer-Reviewed PaperA 2022 Series paper proposes a model of damage and resilience in aging with HIV, asking how care might preserve daily function as well as extend life.